Edible Garden AG Earnings Calls
| Release date | May 15, 2026 |
| EPS estimate | - |
| EPS actual | -$5.25 |
| Revenue estimate | - |
| Revenue actual | 3.341M |
| Release date | Mar 31, 2026 |
| EPS estimate | -$5.60 |
| EPS actual | -$24.81 |
| EPS Surprise | -343.04% |
| Revenue estimate | 5.422M |
| Revenue actual | 4.129M |
| Revenue Surprise | -23.85% |
| Release date | Nov 14, 2025 |
| EPS estimate | -$5.10 |
| EPS actual | -$13.80 |
| EPS Surprise | -170.59% |
| Revenue estimate | 3.876M |
| Revenue actual | 2.817M |
| Revenue Surprise | -27.32% |
| Release date | Aug 14, 2025 |
| EPS estimate | -$0.510 |
| EPS actual | -$65.80 |
| EPS Surprise | -12,801.96% |
| Revenue estimate | 3.876M |
| Revenue actual | 3.146M |
| Revenue Surprise | -18.83% |
Last 4 Quarters for Edible Garden AG
Below you can see how EDBL performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 14, 2025 |
| Price on release | $21.90 |
| EPS estimate | -$0.510 |
| EPS actual | -$65.80 |
| EPS surprise | -12,801.96% |
| Date | Price |
|---|---|
| Aug 08, 2025 | $23.70 |
| Aug 11, 2025 | $23.60 |
| Aug 12, 2025 | $23.30 |
| Aug 13, 2025 | $23.30 |
| Aug 14, 2025 | $21.90 |
| Aug 15, 2025 | $20.70 |
| Aug 18, 2025 | $20.20 |
| Aug 19, 2025 | $20.20 |
| Aug 20, 2025 | $18.80 |
| 4 days before | -7.59% |
| 4 days after | -14.16% |
| On release day | -5.48% |
| Change in period | -20.68% |
| Release date | Nov 14, 2025 |
| Price on release | $13.10 |
| EPS estimate | -$5.10 |
| EPS actual | -$13.80 |
| EPS surprise | -170.59% |
| Date | Price |
|---|---|
| Nov 10, 2025 | $14.40 |
| Nov 11, 2025 | $13.90 |
| Nov 12, 2025 | $13.60 |
| Nov 13, 2025 | $13.40 |
| Nov 14, 2025 | $13.10 |
| Nov 17, 2025 | $12.10 |
| Nov 18, 2025 | $12.60 |
| Nov 19, 2025 | $11.20 |
| Nov 20, 2025 | $10.70 |
| 4 days before | -9.03% |
| 4 days after | -18.31% |
| On release day | -7.63% |
| Change in period | -25.69% |
| Release date | Mar 31, 2026 |
| Price on release | $1.15 |
| EPS estimate | -$5.60 |
| EPS actual | -$24.81 |
| EPS surprise | -343.04% |
| Date | Price |
|---|---|
| Mar 25, 2026 | $1.12 |
| Mar 26, 2026 | $1.15 |
| Mar 27, 2026 | $1.02 |
| Mar 30, 2026 | $0.96 |
| Mar 31, 2026 | $1.15 |
| Apr 01, 2026 | $1.07 |
| Apr 02, 2026 | $1.01 |
| Apr 06, 2026 | $1.07 |
| Apr 07, 2026 | $1.07 |
| 4 days before | 2.68% |
| 4 days after | -6.96% |
| On release day | -6.96% |
| Change in period | -4.46% |
| Release date | May 15, 2026 |
| Price on release | $0.389 |
| EPS estimate | - |
| EPS actual | -$5.25 |
| Date | Price |
|---|---|
| May 11, 2026 | $0.343 |
| May 12, 2026 | $0.352 |
| May 13, 2026 | $0.375 |
| May 14, 2026 | $0.412 |
| May 15, 2026 | $0.389 |
| May 18, 2026 | $0.287 |
| May 19, 2026 | $0.269 |
| May 20, 2026 | $0.277 |
| May 21, 2026 | $0.267 |
| 4 days before | 13.43% |
| 4 days after | -31.41% |
| On release day | -26.30% |
| Change in period | -22.20% |
Edible Garden AG Earnings Call Transcript Summary of Q1 2026
Key investor takeaways: Revenue increased ~22.9% YoY to ~$3.3M in Q1 2026, driven principally by cut herbs (+~46% YoY), condiments (+~51%), vitamins & supplements (+~27%) and a ~50% increase in international sales. Retail footprint now exceeds 6,000 locations (new placements include Target, Safeway, The Fresh Market, Hannaford, Busch's and Woodman's). Management is prioritizing a strategic shift into higher‑margin, shelf‑stable categories — notably ready‑to‑drink (RTD) functional nutrition — and is advancing an Iowa RTD manufacturing initiative in partnership with Tetra Pak and product formulation support from McCormick. Management said prototypes/finalization activity is underway (prototype runs mid‑July, co‑manufacturer production targeted for September) with an in‑house factory expected late‑2027/early‑2028. Operating expenses rose to $10.0M (vs. $5.6M prior year), driven by higher COGS from third‑party sourcing as cut herb distribution scaled and by ~$2.5M of accelerated depreciation linked to the RTD pivot. The company recorded a discrete, nonrecurring income tax benefit of ~$3.4M related to a valuation‑allowance release, reported a net loss of ~$3.7M (vs. $3.3M prior year), and ended the quarter with cash of ~$2.0M (up from $1.1M) after positive operating cash flow of ~$251k. Near‑term priorities: continue retail distribution expansion, transition cut‑herb sourcing to improve margins, scale higher‑margin branded categories, advance RTD capabilities with Tetra Pak and maintain disciplined capital management.
Sign In
Buy EDBL